Navigation Links
PROLOR Biotech Announces Sale of $24.4 Million of Common Stock
Date:3/18/2010

tains forward-looking statements, which may be identified by words such as "expects," "plans," "projects," "will," "may," "anticipates," "believes," "should," "intends," "estimates," "suggests" and other words of similar meaning, including statements regarding the results of current clinical studies and preclinical experiments and the effectiveness of PROLOR's long-acting protein programs, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.  Investors are cautioned that forward-looking statements involve risks and uncertainties that may affect PROLOR's business and prospects, including the risks that PROLOR may not succeed in developing any commercial products, including any long-acting versions of human growth hormone, erythropoietin, interferon beta, GLP-1, and other products; that the long-acting products in development may fail, may not achieve the expected results or effectiveness and/or may not generate data that would support the approval or marketing of these products for the indications being studied or for other indications; that ongoing studies may not continue to show substantial or any activity; that the actual dollar amount of any grants from Israel's Office of the Chief Scientist is uncertain and is subject to policy changes of the Israeli government, and that such grants may be insufficient to assist with product development; and other risks and uncertainties that may cause results to differ materially from those set forth in the forward-looking statements. The results of clinical trials in humans may produce results that differ significantly from the results of clinical and other trials in animals. The results of early-stage trials may differ significantly from the results of more developed, later-stage trials. The development of any products using the CTP platform technology could also be affected by a number of other factors, including unexpected safet
'/>"/>
SOURCE PROLOR Biotech, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
2. Biotech Finishes on a High in August, Burrill Report Says
3. Oncolytics Biotech Inc. reports positive interim results of UK phase Ia/Ib trials
4. Spectrum Pharmaceuticals to Present at the Biotechnology Industry Organization Investor Forum
5. Biotech delists shares from TSXV, continues OTCBB trading
6. Frutarom Gewurzmuller and Blessing Biotech Acquisition Conference Call Scheduled for Monday, October 15, 2007
7. MichBio Announces Formation of Biotechnology Legislative Caucus
8. Oncolytics Biotech Inc. announces approval for UK clinical trial
9. Not just humans benefit from animal biotechnology
10. Biotech adds Central American markets to Sucanon distribution
11. GPC Biotech Today Announced Results of Survival Analysis from the SPARC Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... ... 2015 , ... The new In-Office whitening kit from Whiter ... Clinicians Report is a leading information source to the dental industry. Product reviews ... Image's In-Office whitening kits were favorably validated for use in the dental office. ...
(Date:9/3/2015)... ... September 03, 2015 , ... Local filmmakers and now co-hosts of the ... from Path 11 Productions have had great success in launching their Path11 Podcast with ... House authors, Teal Swan who is the well known Spiritual Catalyst and Linda Howe, ...
(Date:9/3/2015)... Lagos (PRWEB) , ... September 03, 2015 , ... ... base, robust distribution channels and efficient customer and technical support services to promote ... NAFDAC approved 90-day Bridging trial evaluating the efficacy and safety of the product. ...
(Date:9/2/2015)... ... 03, 2015 , ... One can hardly argue against the fact that more ... and personal computers. These devices are being used as GPS, to make purchases, and ... dating apps, STD positive singles can now join the prestigious social ranks of e-dating. ...
(Date:9/2/2015)... (PRWEB) , ... September 02, 2015 , ... Chris Harrison ... September 2015. “It was a simple decision, really,” says Chris. “We have a lot ... They know the brands that work best for them—so we’ve given them the convenience ...
Breaking Medicine News(10 mins):Health News:Whiter Image Products Get Positive Rating From The Clinicians Report 2Health News:Path 11 Podcast Now Features over 20 Metaphysical Discussions on iTunes and Growing 2Health News:Path 11 Podcast Now Features over 20 Metaphysical Discussions on iTunes and Growing 3Health News:Fidson Partners US Firms on New Product Marketing 2Health News:Fidson Partners US Firms on New Product Marketing 3Health News:Fidson Partners US Firms on New Product Marketing 4Health News:Herpes-datingsites.com Recently Added Reviews of 5 STD Dating Apps for STD Positive Singles 2Health News:Harrison's Comfort Footwear Announces Expansion with New CHarrison Online Store 2
... prehypertensive people in morning use, researchers report , , WEDNESDAY, ... control prehypertension, but only if it is taken at ... every morning didn,t lower the blood pressure of prehypertensive ... Hermida reported Wednesday at the American Society of Hypertension ...
... May 14 AstraZeneca (NYSE:,AZN) today announced that ... SEROQUEL(R) (quetiapine fumarate tablets) for the maintenance,treatment of ... to,lithium or divalproex. SEROQUEL is approved by the ... the only single agent approved by the FDA ...
... Amarin Corporation plc,(NASDAQ: AMRN ) today announced ... one ordinary share) ("ADSs") with several new,institutional and ... for up to $60 million funded over two ... entered into definitive agreements for,gross proceeds of up ...
... FRAMINGHAM, Mass., and SYDNEY, Australia, May 14 /PRNewswire-FirstCall/,-- HeartWare ... to,make an investor presentation at the Seventh Annual JMP ... on Wednesday, May 21, 2008. The,conference is being held ... live webcast of the Company,s presentation at the conference ...
... -- Mindray,Medical International Limited (NYSE: MR ), ... in China with a rapidly growing,international presence, today ... of strategic development and Ms. May Li, Mindray,s,investor ... Annual,China Dragon Call Conference to be held at ...
... Families Raise Preschoolers to Be Healthy,Eaters, SACRAMENTO, ... years old experience developmental changes that affect their ... these changes,families can help turn their preschoolers into ... ), According to Monica Montes, a ...
Cached Medicine News:Health News:Aspirin at Bedtime Lowers Blood Pressure 2Health News:FDA Approves AstraZeneca's Seroquel(R) for Maintenance Treatment in Bipolar Disorder 2Health News:FDA Approves AstraZeneca's Seroquel(R) for Maintenance Treatment in Bipolar Disorder 3Health News:FDA Approves AstraZeneca's Seroquel(R) for Maintenance Treatment in Bipolar Disorder 4Health News:FDA Approves AstraZeneca's Seroquel(R) for Maintenance Treatment in Bipolar Disorder 5Health News:FDA Approves AstraZeneca's Seroquel(R) for Maintenance Treatment in Bipolar Disorder 6Health News:FDA Approves AstraZeneca's Seroquel(R) for Maintenance Treatment in Bipolar Disorder 7Health News:FDA Approves AstraZeneca's Seroquel(R) for Maintenance Treatment in Bipolar Disorder 8Health News:FDA Approves AstraZeneca's Seroquel(R) for Maintenance Treatment in Bipolar Disorder 9Health News:Amarin Announces Private Placement for up to $60 Million 2Health News:Amarin Announces Private Placement for up to $60 Million 3Health News:Amarin Announces Private Placement for up to $60 Million 4Health News:Amarin Announces Private Placement for up to $60 Million 5Health News:HeartWare to Present at Seventh Annual JMP Securities Research Conference 2Health News:Mindray to Present at the Oppenheimer 2nd Annual China Dragon Call Conference and 2008 Citi Investment Research Global Healthcare Conference 2Health News:Learning Good Eating Habits Early Leads to Lifelong Health and Wellness 2
(Date:9/2/2015)... , Sept. 2, 2015 About Neuroendovascular ... used to treat an unruptured and ruptured brain ... The treatment is either known as an endovascular ... endovascular coil blocks the blood flow in an ... under general anaesthesia by an interventional neuroradiologist using ...
(Date:9/2/2015)...  Array BioPharma Inc. (Nasdaq: ARRY ) ... Ron Squarer , will present at the Wells ... is welcome to participate in the conference through ... Fargo Securities Healthcare ConferencePresenter: Ron Squarer, Chief Executive ... a.m. Eastern Time Webcast: www.arraybiopharma.com   ...
(Date:9/2/2015)... Pa. , Sept. 2, 2015 ... increases, diversifies revenue base with highly profitable specialty ... , Near-term growth potential with 11 product ... include Paragraph IV certifications  , Provides medium ... candidates in development, including eight controlled substances ...
Breaking Medicine Technology:Global Neuroendovascular Coil Market 2015-2019 2Lannett To Acquire Kremers Urban Pharmaceuticals For $1.23 Billion 2Lannett To Acquire Kremers Urban Pharmaceuticals For $1.23 Billion 3Lannett To Acquire Kremers Urban Pharmaceuticals For $1.23 Billion 4Lannett To Acquire Kremers Urban Pharmaceuticals For $1.23 Billion 5Lannett To Acquire Kremers Urban Pharmaceuticals For $1.23 Billion 6
... The combination of these recommendations with the ... Sorin Group has resulted in numerous improvements, ... poles and reservoir holder for hassle-free storage ... cart with just a flick of the ...
The S4 Spinal System has quickly gained a reputation for being the next generation in pedicle screw systems because of its exceptionally small size and high biomechanical strength....
... Diagnostics is a clinical reference ... treatment and monitoring of hemostatic ... a collaboration of four laboratory ... defined vision to deliver customizable ...
All-natural porcine collagen can be used in open or laparoscopic placement....
Medicine Products: